|
Tbi-223
|
T932717-1mg
|
≥99% |
2071265-08-0 |
1mg
|
¥ 1818.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Thalidomide-O-amido-C3-PEG3-C1-NH2
|
T932703-5mg
|
≥99% |
1799711-29-7 |
5mg
|
¥ 1900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Thalidomide-O-amido-C3-PEG3-C1-NH2
|
T932703-25mg
|
≥99% |
1799711-29-7 |
25mg
|
¥ 5500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Thalidomide-O-amido-C3-PEG3-C1-NH2
|
T932703-10mg
|
≥99% |
1799711-29-7 |
10mg
|
¥ 3200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2-(4-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenylamino)quinazolin-6-ylamino)-4-methyl-4,5-dihydrooxazol-4-yl)methanol
|
T932126-5mg
|
≥99% |
937263-81-5 |
5mg
|
¥ 1450.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2-(4-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenylamino)quinazolin-6-ylamino)-4-methyl-4,5-dihydrooxazol-4-yl)methanol
|
T932126-25mg
|
≥99% |
937263-81-5 |
25mg
|
¥ 4500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2-(4-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenylamino)quinazolin-6-ylamino)-4-methyl-4,5-dihydrooxazol-4-yl)methanol
|
T932126-10mg
|
≥99% |
937263-81-5 |
10mg
|
¥ 2300.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Terpendole I
|
T929537-1mg
|
|
167612-17-1 |
1mg
|
¥ 3240.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Theodrenaline hydrochloride
|
T928856-5mg
|
|
2572-61-4 |
5mg
|
¥ 4800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Theodrenaline hydrochloride
|
T928856-1mg
|
|
2572-61-4 |
1mg
|
¥ 1920.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
β-D-半乳糖基-(1→3)-N-乙酰基-D-半乳糖胺
|
T926600-5mg
|
|
3554-90-3 |
5mg
|
¥ 8800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
β-D-半乳糖基-(1→3)-N-乙酰基-D-半乳糖胺
|
T926600-1mg
|
|
3554-90-3 |
1mg
|
¥ 4280.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
组织消化液
|
T767918-50ml
|
BioReagent, 无菌过滤, 即用型 |
N/A |
50ml
|
¥ 1699.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
肿瘤组织消化液
|
T767917-50ml
|
BioReagent, 无菌过滤, 即用型 |
N/A |
50ml
|
¥ 269.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
TMB显色液(组化或膜HRP显色用)
|
T743339-2×50ml
|
BioReagent, for western blot, 适用于免疫组织化学(for IHC), 即用型, 无菌 |
N/A |
2×50ml
|
¥ 299.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
TMB显色液(组化或膜HRP显色用)
|
T743339-2×250ml
|
BioReagent, for western blot, 适用于免疫组织化学(for IHC), 即用型, 无菌 |
N/A |
2×250ml
|
¥ 899.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
TBA-354
|
T733022-1mg
|
≥98% |
1257426-19-9 |
1mg
|
¥ 119.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
TBA-354
|
T733022-100mg
|
≥98% |
1257426-19-9 |
100mg
|
¥ 2619.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-((5-硫代-4,5-二氢-1,3,4-噻二唑-2-基)硫基)乙酸乙酯
|
T699389-25g
|
≥97% |
83123-75-5 |
25g
|
¥ 999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(S)-1,1,1-三氟丙烷-2-胺
|
T690547-250mg
|
≥98% |
125278-10-6 |
250mg
|
¥ 889.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-羟基-1,2,3,4-四氢异喹啉
|
T690529-50mg
|
≥98% |
102877-50-9 |
50mg
|
¥ 216.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
反式-4-氨基环己烷羧酸乙酯
|
T690456-5g
|
≥95% |
1678-68-8 |
5g
|
¥ 1875.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶
|
T690441-50mg
|
≥98% |
410544-19-3 |
50mg
|
¥ 199.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶
|
T690441-250mg
|
≥98% |
410544-19-3 |
250mg
|
¥ 699.9
|
期货,请咨询 |
|
0 |
阿拉丁 |